Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WL8713 in Primary Axillary Hyperhidrosis
NCT02193139Phase 2Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WL-8713 in primary axillary hyperhidrosis (PAH), sponsored by Watson Pharmaceuticals. Started Dec 2013; status: completed.
02
Drugs
WL-8713
03
Conditions
primary axillary hyperhidrosis (PAH)
Beyond the preview
Go deeper on NCT02193139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02193139.